• 1. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

3-Bromo-4-Hydroxy-5-Methoxybenzene-1-Carboximidamide

3-Bromo-4-Hydroxy-5-Methoxybenzene-1-Carboximidamide (CAS No. 32048-18-3) is a structurally complex organic compound that has garnered attention in various fields of chemistry, particularly in medicinal chemistry and materials science. This compound is characterized by its aromatic benzene ring, which is substituted with a bromine atom at the 3-position, a hydroxyl group at the 4-position, a methoxy group at the 5-position, and a carboximidamide group at the 1-position. The combination of these substituents imparts unique chemical and physical properties to the molecule, making it a valuable compound for research and development.

The carboximidamide functional group at the 1-position of the benzene ring is particularly noteworthy. This group is known for its ability to form hydrogen bonds, which can significantly influence the compound's solubility, stability, and reactivity. Recent studies have explored the potential of carboximidamides as bioisosteres in drug design, where they can replace carboxylic acids or amides in small molecules to improve pharmacokinetic properties such as absorption and metabolism. The presence of this group in 3-Bromo-4-Hydroxy-5-Methoxybenzene-1-Carboximidamide makes it a promising candidate for further exploration in drug discovery.

The bromine atom at the 3-position contributes to the compound's electronic properties. Bromine is an electron-withdrawing group, which can deactivate the aromatic ring and influence the reactivity of other substituents. This effect is particularly relevant in reactions involving electrophilic substitution or nucleophilic aromatic substitution. Researchers have recently investigated how halogen substituents like bromine can modulate the electronic environment of aromatic compounds, leading to novel applications in organic synthesis and catalysis.

The hydroxyl group at the 4-position introduces hydrophilicity to the molecule. This property is crucial for applications where solubility in polar solvents is required, such as in pharmaceutical formulations or analytical chemistry. Additionally, the hydroxyl group can participate in hydrogen bonding, further enhancing the compound's ability to interact with other molecules. Recent advancements in green chemistry have highlighted the importance of hydroxyl-containing compounds in designing sustainable chemical processes.

The methoxy group at the 5-position is an electron-donating group that activates the aromatic ring toward electrophilic substitution. This activation can facilitate various synthetic transformations, making 3-Bromo-4-Hydroxy-5-Methoxybenzene-1-Carboximidamide a versatile building block in organic synthesis. Moreover, methoxy groups are known to enhance bioavailability when present in drug molecules, which aligns with current trends in medicinal chemistry focusing on improving drug delivery systems.

Recent studies have also explored the potential of 3-Bromo-4-Hydroxy-5-Methoxybenzene-1-Carboximidamide as an intermediate in the synthesis of bioactive compounds. For instance, researchers have utilized this compound as a precursor for constructing heterocyclic frameworks with potential anticancer or anti-inflammatory activities. The ability to modify this compound through various substitution reactions has opened new avenues for developing novel therapeutic agents.

In terms of synthesis, 3-Bromo-4-Hydroxy-5-Methoxybenzene-1-Carboximidamide can be prepared via multi-step organic reactions involving bromination, oxidation, and amidation steps. These methods often require precise control over reaction conditions to ensure high yields and purity. Advances in catalytic methodologies and green chemistry practices have made these syntheses more efficient and environmentally friendly.

From an analytical standpoint, modern techniques such as high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) spectroscopy are commonly employed to characterize this compound. These tools provide detailed insights into its molecular structure and purity, ensuring its reliability for downstream applications.

Looking ahead, 3-Bromo-4-Hydroxy-5-Methoxybenzene-1-Carboximidamide holds significant potential for further exploration in areas such as drug delivery systems, material science, and catalysis. Its unique combination of functional groups makes it a valuable asset for researchers seeking to develop innovative chemical solutions.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)